Keyphrases
Lymphocytes
100%
Receptor Expression
100%
Cyclosporine
100%
Soluble interleukin-2 Receptor (sIL-2R)
100%
Methylprednisolone
60%
Suppression Effect
60%
Control Subjects
40%
Lymphocyte Proliferation
40%
Prednisolone
40%
Glomerulopathy
40%
Interleukin-2
20%
Cell Surface Receptor
20%
Predictive Value
20%
Clinical Response
20%
Immune System
20%
Response to Treatment
20%
Peripheral Blood Mononuclear Cells
20%
Treatment Verification
20%
Cellular Mechanisms
20%
Therapeutic Efficacy
20%
Pharmacodynamics
20%
Multidrug
20%
Proliferation in Vitro
20%
Immunosuppressive Regimens
20%
Interindividual Heterogeneity
20%
Neuroscience
Lymphocyte
100%
Ciclosporin
100%
Receptor Expression
100%
Glucocorticoid
100%
Interleukin 2 Receptor
100%
Methylprednisolone
60%
In Vitro
40%
Lymphocyte Proliferation
40%
Prednisolone
40%
Interleukin 2
20%
Peripheral Blood Mononuclear Cell
20%
Immunosuppressive Drug
20%
Phytohaemagglutinin
20%
Cell Surface Receptor
20%
Immunology and Microbiology
Lymphocyte
100%
Ciclosporin
100%
Glucocorticoid
100%
Interleukin 2 Receptor
100%
Methylprednisolone
60%
Lymphocyte Proliferation
40%
Prednisolone
40%
Interleukin 2
20%
Cell Surface
20%
Immune System
20%
Phytohaemagglutinin
20%
Peripheral Blood Mononuclear Cell
20%
Immunosuppressive Drug
20%
Pharmacodynamics
20%
Pharmacology, Toxicology and Pharmaceutical Science
Glucocorticoid
100%
Ciclosporin
100%
Interleukin 2 Receptor
100%
Methylprednisolone
60%
Prednisolone
40%
Glomerulopathy
40%
Interleukin 2
20%
Pharmacodynamics
20%
Combination Therapy
20%
Immunosuppressive Agent
20%
Phytohaemagglutinin
20%
Cell Surface Receptor
20%